• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.65% Nasdaq Up 0.22%

    Valeant Pharmaceuticals International, Inc. (VRX)

    -NYSE
    144.42 Down 1.64(1.12%) 3:07PM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:146.06
    Open:146.30
    Bid:144.53 x 400
    Ask:144.59 x 200
    1y Target Est:52.38
    Beta:0.72
    Next Earnings Date:N/A
    Day's Range:144.13 - 149.90
    52wk Range:106.00 - 153.10
    Volume:1,842,128
    Avg Vol (3m):2,619,110
    Market Cap:48.48B
    P/E (ttm):97.52
    EPS (ttm):1.48
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    VRXDown 1.12%48.48B
    TEVAUp 0.85%50.00B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):6.10
    Ex-Dividend Date:10-Nov-10

    Analysts

    Annual EPS Est (Dec-10) :N/A
    Quarterly EPS Est (Sep-10) :N/A
    Mean Recommendation*:3.0
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter (OTC) products, and medical devices in the areas of eye health, dermatology, and neurology therapeutic classes worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback